Public Health Agency of Canada
The agency relied on two internal drug-report searches in May and July 2001 that found no adverse drug reports involving OxyContin.1. The 2006 revision merely added the word "usually" to the misleading claim — i.e., "Drug abuse is usually not a problem…"2.
The agency relied on two internal drug-report searches in May and July 2001 that found no adverse drug reports involving OxyContin.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
The 2006 revision merely added the word "usually" to the misleading claim — i.e., "Drug abuse is usually not a problem…"
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
Health Canada was aware of the FDA action and treats the FDA as a reliable source of information for monitoring drugs for safety problems, specifically with regard to prescription drug abuse.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
Valerian Labs was Health Canada-licensed to manufacture natural health products
Health Canada began collecting user fees from pharmaceutical companies in 1994
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
Xylazine first appeared in Health Canada DAS samples in 2018
How We Got Here: A Field Guide to the Fentanyl Crisis in Can
OxyContin was approved by Health Canada in 1996
How We Got Here: A Field Guide to the Fentanyl Crisis in Can
expanded naloxone distribution as the single most likely factor in the modest 2024 mortality decline
How We Got Here: A Field Guide to the Fentanyl Crisis in Can
These are things people say about Public Health Agency of Canada that aren't settled fact — each one attributed to who's actually claiming it, so a claim never quietly passes as established just because it showed up in a document. Weigh it yourself.
"the regulatory delay was a material contributor to the Canadian over-prescription epidemic"
"the naloxone-only response is inadequate for the new pharmacology"
"the appearance of these wounds among the visibly homeless population has accelerated through 2023–2026"
"Health Canada's delayed response allowed Purdue to use the misleading information in its promotional materials for more than 10 years (1996–2006)."
"Health Canada's role in precipitating the overdose crisis has not received greater scrutiny"